Numerous studies have shown that UBE2T, as an oncogene, plays a role in a variety of tumours, including breast cancer, liver cancer, lung cancer, prostate cancer, kidney cancer, bladder cancer, glioma, etc. [20, 22, 25, 27, 29–32]. This evidence concerns the gene UBE2T and prostate carcinoma.